GSK PLC (GSK)
33.96
+0.26
(+0.77%)
USD |
NYSE |
Nov 22, 16:00
34.14
+0.18
(+0.53%)
After-Hours: 20:00
GSK Cash from Operations (Quarterly): 2.885B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.885B |
| June 30, 2024 | 1.398B |
| March 31, 2024 | 1.215B |
| December 31, 2023 | 3.899B |
| September 30, 2023 | 2.821B |
| June 30, 2023 | 1.638B |
| March 31, 2023 | 64.42M |
| December 31, 2022 | 2.697B |
| September 30, 2022 | 1.220B |
| June 30, 2022 | 1.841B |
| March 31, 2022 | 3.411B |
| December 31, 2021 | 5.170B |
| September 30, 2021 | 3.502B |
| June 30, 2021 | 1.812B |
| March 31, 2021 | 456.28M |
| December 31, 2020 | 4.907B |
| September 30, 2020 | 1.307B |
| June 30, 2020 | 3.383B |
| March 31, 2020 | 1.237B |
| December 31, 2019 | 4.613B |
| September 30, 2019 | 2.990B |
| June 30, 2019 | 1.773B |
| March 31, 2019 | 863.72M |
| December 31, 2018 | 5.632B |
| September 30, 2018 | 2.572B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.832B |
| March 31, 2018 | 1.200B |
| December 31, 2017 | 3.632B |
| September 30, 2017 | 2.549B |
| June 30, 2017 | 1.334B |
| March 31, 2017 | 1.417B |
| December 31, 2016 | 4.198B |
| September 30, 2016 | 2.107B |
| June 30, 2016 | 1.778B |
| March 31, 2016 | 720.05M |
| December 31, 2015 | 2.271B |
| September 30, 2015 | 755.80M |
| June 30, 2015 | 338.30M |
| March 31, 2015 | 560.83M |
| December 31, 2014 | 3.580B |
| September 30, 2014 | 2.103B |
| June 30, 2014 | 1.315B |
| March 31, 2014 | 1.534B |
| December 31, 2013 | 3.492B |
| September 30, 2013 | 3.264B |
| June 30, 2013 | 2.606B |
| March 31, 2013 | 1.937B |
| December 31, 2012 | 3.047B |
| September 30, 2012 | -465.79M |
| June 30, 2012 | 2.762B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
64.42M
Minimum
Mar 2023
5.170B
Maximum
Dec 2021
2.474B
Average
2.269B
Median
Cash from Operations (Quarterly) Benchmarks
| AstraZeneca PLC | 3.383B |
| Merck & Co Inc | 9.291B |
| Pfizer Inc | 6.714B |
| Sanofi SA | -- |
| Moderna Inc | -1.566B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -926.64M |
| Cash from Financing (Quarterly) | -1.718B |
| Free Cash Flow | 6.053B |
| Free Cash Flow Per Share (Quarterly) | 0.8449 |
| Free Cash Flow to Equity (Quarterly) | 1.689B |
| Free Cash Flow to Firm (Quarterly) | 1.913B |
| Free Cash Flow Yield | 8.64% |